Literature DB >> 11686471

The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations.

H A Weiss1, A Buvé, N J Robinson, E Van Dyck, M Kahindo, S Anagonou, R Musonda, L Zekeng, L Morison, M Caraël, M Laga, R J Hayes.   

Abstract

OBJECTIVES: To estimate age- and sex-specific herpes simplex virus type-2 (HSV-2) prevalence in urban African adult populations and to identify factors associated with infection. DESIGN AND METHODS: Cross-sectional, population-based samples of about 2000 adults interviewed in each of the following cities: Cotonou, Benin; Yaoundé, Cameroon; Kisumu, Kenya and Ndola, Zambia. Consenting study participants were tested for HIV, HSV-2 and other sexually transmitted infections.
RESULTS: HSV-2 prevalence was over 50% among women and over 25% among men in Yaoundé, Kisumu and Ndola, with notably high rates of infection among young women in Kisumu and Ndola (39% and 23%, respectively, among women aged 15-19 years). The prevalence in Cotonou was lower (30% in women and 12% in men). Multivariate analysis showed that HSV-2 prevalence was significantly associated with older age, ever being married, and number of lifetime sexual partners, in almost all cities and both sexes. There was also a strong, consistent association with HIV infection. Among women, the adjusted odds ratios for the association between HSV-2 and HIV infections ranged from 4.0 [95% confidence interval (CI) = 2.0-8.0] in Kisumu to 5.5 (95% CI = 1.7-18) in Yaoundé, and those among men ranged from 4.6 (95% CI = 2.7-7.7) in Ndola to 7.9 (95% CI = 4.1-15) in Kisumu.
CONCLUSIONS: HSV-2 infection is highly prevalent in these populations, even at young ages, and is strongly associated with HIV at an individual level. At a population level, HSV-2 prevalence was highest in Kisumu and Ndola, the cities with the highest HIV rates, although rates were also high among women in Yaoundé, where there are high rates of partner change but relatively little HIV infection. The high prevalence of both infections among young people underlines the need for education and counselling among adolescents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686471     DOI: 10.1097/00002030-200108004-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  78 in total

1.  Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.

Authors:  Edith Nakku-Joloba; Fred Kambugu; Julius Wasubire; Joshua Kimeze; Robert Salata; Jeffrey M Albert; Alfred Rimm; Christopher Whalen
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

Review 2.  Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries.

Authors:  S Mullick; D Watson-Jones; M Beksinska; D Mabey
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

3.  In Vitro and In Vivo Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital Infection.

Authors:  James Hopkins; Tejabhiram Yadavalli; Rahul Suryawanshi; Farreh Qatanani; Ipsita Volety; Ram Koganti; Aqsa Iqbal; Deepak Shukla
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial.

Authors:  Muzala Kapina; Cheri Reid; Karisse Roman; Elena Cyrus-Cameron; Antonia Kwiecien; Stephen Weiss; Sten H Vermund
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

5.  Correlates of prevalent sexually transmitted infections among participants screened for an HIV incidence cohort study in Kisumu, Kenya.

Authors:  Fredrick Odhiambo Otieno; Richard Ndivo; Simon Oswago; Sherri Pals; Robert Chen; Timothy Thomas; Ernesta Kunneke; Lisa A Mills; Eleanor McLellan-Lemal
Journal:  Int J STD AIDS       Date:  2014-05-08       Impact factor: 1.359

6.  Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.

Authors:  Eddy van Dyck; Anne Buvé; Helen A Weiss; Judith R Glynn; David W G Brown; Bénédicte De Deken; John Parry; Richard J Hayes
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Herpes simplex virus-2 infection in male rural migrants in Shanghai, China.

Authors:  N He; H Cao; Y Yin; M Gao; T Zhang; R Detels
Journal:  Int J STD AIDS       Date:  2009-02       Impact factor: 1.359

8.  Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study.

Authors:  Junia Rodrigues; Beatriz Grinsztejn; Francisco I Bastos; Luciane Velasque; Paula M Luz; Claudia T V de Souza; Ingebourg Georg; Jose H Pilotto; Valdilea G Veloso
Journal:  BMC Infect Dis       Date:  2009-04-01       Impact factor: 3.090

9.  Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa.

Authors:  R G White; E E Freeman; K K Orroth; R Bakker; H A Weiss; N O'Farrell; A Buvé; R J Hayes; J R Glynn
Journal:  Sex Transm Infect       Date:  2008-10       Impact factor: 3.519

10.  Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part.

Authors:  Haeng Seop Shin; Jeong Joo Park; Chaeshin Chu; Hyeon Je Song; Kyung Soon Cho; Joo Shil Lee; Sung Soon Kim; Mee Kyung Kee
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.